Sign in
4

Changes in Ownership

Adaptive Biotechnologies Corp Filed Acc 0001209191-21-034235

Director sold 2,500 shares at $35.00 ($87,500)

  • Director acquired 2,500 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
GRIFFIN MICHELLE RENEE Director 2021-05-18 Option exercise +2,500 $7.80 $19,500 4,004 D
GRIFFIN MICHELLE RENEE Director 2021-05-18 Sale −2,500 $35.00 $87,500 1,504 D
Derivatives
GRIFFIN MICHELLE RENEE Director 2021-05-18 Option exercise · Stock Option (Right to Buy) −2,500 76,000 D
Open-market sales · 2,500 sh · avg $35.00 · $87,500
Loading xslF345X03/doc4.xml…